• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » St. Jude Medical picks up where Medtronic left off with Novation

St. Jude Medical picks up where Medtronic left off with Novation

April 8, 2011 By MassDevice staff

St. Jude Medical (NYSE:STJ) snatched a contract from group purchasing organization Novation after its Twin Cities competitor Medtronic (NYSE:MDT) walked away from a similar deal with the GPO in February.

Novation said the 30-month deal, which went into effect April 1, will see St. Jude supply it with cardiac rhythm management products — which were also part of the deal Medtronic spiked, which also included some orthopedic products. It includes provisions for "locally-negotiated pricing and market share growth rebates," according to a press release, and is the first time the two companies have worked together.

Medtronic made headlines — pleased Wall Street — when it canceled several contracts for its cardiovascular and orthopedic products with Novation worth an estimated $2 billion a year. A few weeks later the Fridley, Minn.-based medical device giant spiked a deal with Premier Inc. for some of its spine products.

After the Premier deal ended, Medtronic spokesman Chris Garland told MassDevice in an email that the decision to end both deals were made because the company felt it would do better negotiating contracts directly with hospitals.

“Our only comment is that we are confirming that our spinal business terminated a national contract with Premier,” Garland wrote. “We did this for the same reasons we terminated five Novation contracts earlier.”

Last month, Medtronic CFO Gary Ellis told analysts that spiking the deals wasn’t a strut in a larger strategic plan.

"There’s a lot of speculation around here that a strategic change is going on,” Ellis told analysts at the Barclay’s Capital Investors Conference in Miami. “That is not the case.”

GPOs play a significant role in the delivery of healthcare, Ellis noted, and they’re beneficial in streamlining the process of selling into hospital systems.

“We intend to maintain our relationships with GPOs that are providing a benefit,” he said.

Yesterday, Garland told us Medtronic that the company’s move to combine its cardiac and vascular groups’ sales forces into a single cross-divisional organization is part of its move to deal directly with hospital purchasing administrators.

Filed Under: News Well Tagged With: Cardiac Rhythm Management, stjudemedical

More recent news

  • Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
  • Edwards Lifesciences taps GE HealthCare vet to head new digital engineering group
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • GE HealthCare taps retiring AT&T CFO for board of directors
  • Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy